Treating Fibromyalgia and Pain in Psychiatry

December, 2008 | Vol: 6 Issue: 12

In this issue

Learning Objective

Learning Objectives, Dec. 2008

This CME/CE activity is intended for psychiatrists, psychiatric nurses, psychologists and other health care professionals with
an interest in the diagnosis and treatment of psychiatric disorders.

Editorial Information


Medications for Fibromyalgia

Recently, the FDA gave its first two approvals for medications to treat fibromyalgia (FM): first Lyrica (pregabalin) and then Cymbalta (duloxetine). While it is nice that FM is receiving some attention from big pharma, the badge of FDA approval should be taken with a grain of salt.

Cymbalta For Physical Pain in Depression: Fact or Fiction?

It has become increasingly clear that depressed patients quite often suffer from some degree of physical pain, which may adversely impact treatment outcome. Indeed, research suggests that as the pain severity of patients increases, the odds of achieving a successful antidepressant response decreases (Bair MJ et al., Psychosom Med 2004;66:17-22). Given that pain is associated with poor treatment response, a clear need exists for treatments that can effectively target both depression and physical pain.
Enter Cymbalta (duloxetine), Eli Lilly’s popular antidepressant.

Expert QA